BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26133969)

  • 1. Therapeutic Effectiveness in the Treatment of Experimental Bacterial Keratitis with Ion-activated Mucoadhesive Hydrogel.
    Kesavan K; Kant S; Pandit JK
    Ocul Immunol Inflamm; 2016 Oct; 24(5):489-92. PubMed ID: 26133969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
    Bharti SK; Kesavan K
    Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
    Shastri DH; Prajapati ST; Patel LD
    Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
    Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmic delivery of sparfloxacin from in situ gel formulation for treatment of experimentally induced bacterial keratitis.
    Nesseem DI
    Drug Test Anal; 2011 Feb; 3(2):106-15. PubMed ID: 21322120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis.
    Romanowski EG; Mah FS; Kowalski RP; Yates KA; Gordon YJ
    J Ocul Pharmacol Ther; 2008 Aug; 24(4):380-4. PubMed ID: 18665809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits.
    Oksuz H; Duran N; Tamer C; Cetin M; Silici S
    Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system.
    Kesavan K; Nath G; Pandit J
    Daru; 2010; 18(4):237-46. PubMed ID: 22615622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
    Ghelardi E; Tavanti A; Davini P; Celandroni F; Salvetti S; Parisio E; Boldrini E; Senesi S; Campa M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3396-401. PubMed ID: 15328102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Fukaya Y; Kurita A; Tsuruga H; Naito A; Nakaya S; Sato M; Kamata Y; Hirata H; Kambara Y; Kurasawa N; Wada T; Toyoda Y; Shirasawa E; Ohashi Y
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):258-66. PubMed ID: 16910867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
    Chang VS; Dhaliwal DK; Raju L; Kowalski RP
    Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus].
    Wang J; Li X; Xiong L; Sun N
    Yan Ke Xue Bao; 2008 Mar; 24(1):18-22. PubMed ID: 18709951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S; Talele GS
    Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.